A brief screening checklist may flag patients with suspected polyethylene glycol allergy to help guide the selection of ...
Flow Space on MSN
This CEO Lost Family to Cancer. Now, He’s Banking on Radically Transforming Early Detection of Breast Cancer
When Jayant Parthasarathy lost family members to breast, brain, ovarian, and prostate cancers, his next mission was clear.
MedPage Today on MSN
MicroRNA Tests Eyed for Flagging Heart Transplant Rejection
The noninvasive diagnosis of allograft rejection after heart transplantation may be on the horizon, according to findings ...
Zacks.com on MSN
Can GE (GE) Keep the Earnings Surprise Streak Alive?
GE (GE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients ...
Zacks.com on MSN
Why Amphenol (APH) is Poised to Beat Earnings Estimates Again
Amphenol (APH) has an impressive earnings surprise history and currently possesses the right combination of the two key ...
Zacks.com on MSN
Will MasterCraft Boat Holdings, Inc. (MCFT) Beat Estimates Again in Its Next Earnings Report?
MasterCraft Boat Holdings, Inc. (MCFT) has an impressive earnings surprise history and currently possesses the right ...
M&T Bank (MTB) has an impressive earnings surprise history and currently possesses the right combination of the two key ...
Cautionary Statement Regarding Forward-Looking Information In this report, “Value Line,” “we,” “us,” “our” refers to Value Line, Inc. and “the Company” refers to Value Line and its subsidiaries unless ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
The combination of axi-cel and rituximab showed high efficacy in refractory LBCL, with a 73% complete response rate and 88% overall response rate. Safety was favorable, with no new signals; 96% ...
Zacks Investment Research on MSN
Why Stifel (SF) could beat earnings estimates again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
Zacks Investment Research on MSN
Will Rollins (ROL) beat estimates again in its next earnings report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results